Evaluación de los comparadores empleados en los estudios pivotales de nuevos medicamentos e indicaciones von Alegre-del-Rey, EJ, Fénix-Caballero, Moreno Ramos

Volltext

6ER-009 Comparative efficacy of abemaciclib and palbociclib as adjuvant treatment in patients with early breast cancer von Ganfornina Andrades, A, Salguero Olid, A, Alegre Del-Rey, EJ, Fenix Caballero, S

Volltext

4CPS-166 Association between immune-related effects and effectiveness of first-line pembrolizumab in advanced non-small-cell lung cancer von Martínez Díaz, C, Fenix Caballero, S, Cercos Lleti, AC, Gil Sierra, MD, Alegre del Rey, EJ

Volltext

Expresiones y criterios mejorables en la redacción de informes de evaluación y posicionamiento terapéutico von Alegre del Rey, EJ, Ortega Eslava, Fénix-Caballero, Fraga Fuentes, Martínez López, Hoyo Gil

Volltext

Coste-efectividad del evolocumab. Respuesta von Olry de Labry Lima, Antonio, Matas Hoces, Antonio, Alegre del Rey, Emilio Jesús, Gimeno Ballester, Vicente

Volltext

2SPD-009 Analysis of olaparib and talazoparib as possible therapeutic alternatives in advanced breast cancer and a germline BRCA mutation von Camean-Castillo, M, Fenix-Caballero, S, Gil-Sierra, MD, Briceño-Casado, MP, Salmeron-Navas, FJ, Alegre del Rey, EJ, Rios-Sanchez, E, Diaz-Navarro, J, Martinez-Diaz, C, Borrero-Rubio, JM

Volltext

1ISG-009 Economic impact of aflibercept optimisation for the treatment of eye-related conditions von Garciadeparedes-Esteban, JC, Gil-Sierra, MD, Rios-Sanchez, E, Camean-Castillo, M, Diaz-Navarro, J, Rey, EJ Alegre-Del, Lopez-Vallejo, J, Martinez-Diaz, C, Palomo-Palomo, C, Briceño-Casado, MDP, Borrero-Rubio, JM

Volltext

4CPS-161 Determination of drug serum levels to optimise treatment of patients with psoriasis von Camean-Castillo, M, Rios-Sanchez, E, Gil-Sierra, MD, Briceño-Casado, MDP, Palomo-Palomo, C, Borrero-Rubio, JM, Rey, EJ Alegre-Del, Diaz-Navarro, J, Martinez-Diaz, C, Salmeron-Navas, FJ

Volltext

4CPS-150 Use of adalimumab for hidradenitis suppurativa von Gil-Sierra, MD, Garciadeparedes-Esteban, JC, Rios-Sanchez, E, Briceño-Casado, MDP, Palomo-Palomo, C, Diaz-Navarro, J, Rey, EJ Alegre-Del, Martinez-Diaz, C, Lopez-Vallejo, JF, Borrero-Rubio, JM

Volltext

CP-140 Analysis of distribution and acceptability of pharmaceutical interventions after implantation of the electronic assisted prescription von Gil-Sierra, MD, Diaz-Navarro, J, Camean-Castillo, M, Fenix-Caballero, S, GarciadeParedes-Esteban, JC, Blanco-Castaño, MA, Gandara-LadrondeGuevara, MJ, Martinez-Diaz, C, Borrero-Rubio, JM, Rey, EJ Alegre-Del

Volltext

Píldora poscoital: un debate científico necesario von Alegre-del Rey, Emilio Jesús, Fénix-Caballero, Silvia, Díaz-Navarro, Jorge, Rodríguez-Martín, Esteban

Volltext

Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis von Fénix-Caballero, S., Alegre-del Rey, E. J., Castaño-Lara, R., Puigventós-Latorre, F., Borrero-Rubio, J. M., López-Vallejo, J. F.

Volltext

Evaluación y posicionamiento de medicamentos como alternativas terapéuticas equivalentes von Alegre del Rey, Emilio Jesús, Fénix Caballero, Silvia, Castaño Lara, Rocío, Sierra García, Francisco

Volltext

DI-063 Survival benefit with vemurafenib in ‘braf’ mutation positive melanoma: Area under the curve based reanalysis von Fenix-Caballero, S, Diaz-Navarro, J, Camean-Castillo, M, Rey, EJ Alegre-del, Palomo-Palomo, C, Blanco-Castaño, MA, Borrero-Rubio, JM, Gandara-LadronDeGuevara, MJ, GarciaDeParedes-Esteban, JC, Gil-Sierra, D

Volltext

2SPD-006 Are all biologic agents in the treatment of ankylosing spondylitis equivalent alternatives? von García Giménez, I, Montero Perez, O, Rodriguez Jorge, M, Fenix-Caballero, S, Alegre-Del Rey, EJ

Volltext

1ISG-004 Economic comparison of therapeutic alternatives for firstline treatment of multiple myeloma von Gil-Sierra, MD, Fenix-Caballero, S, Briceño-Casado, MDP, Dominguez-Cantero, M, Alegre-Del Rey, EJ

Volltext

4CPS-132 Indirect treatment comparison of anti-calcitonin gene related peptide pathway antibodies in chronic migraine von Briceño Casado, MDP, Fenix-Caballero, S, Gil-Sierra, MD, Dominguez Cantero, M, Alegre-Del Rey, EJ

Volltext

4CPS-076 Indirect comparison between pembrolizumab monotherapy and pembrolizumab chemotherapy regimens in squamous lung cancer von Briceño Casado, MDP, Gil-Sierra, MD, Fenix-Caballero, S, Dominguez-Cantero, M, Alegre-Del Rey, EJ

Volltext

1ISG-021 Indirect comparison of brigatinib versus alectinib in ALK positive non-small cell lung cancer von Salmeron Navas, FJ, Fenix-Caballero, S, Moreno-Ramos, C, Dominguez Cantero, M, Barreiro-Fernandez, EM, Alegre-Del Rey, EJ

Volltext

2SPD-031 Subgroup analysis about efficacy of early use of remdesivir in COVID-19 von Gil-Sierra, MD, Briceño-Casado, MDP, Sanchez-Hidalgo, M, Alarcon De La Lastra-Romero, C, De La Calle-Riaguas, B, Dominguez-Cantero, M, Alegre-Del Rey, EJ

Volltext